<DOC>
	<DOCNO>NCT00031746</DOCNO>
	<brief_summary>RATIONALE : Soy protein supplement may prevent delay development prostate cancer patient elevate prostate-specific antigen ( PSA ) level . PURPOSE : Randomized phase II trial determine effectiveness soy protein supplement prevent prostate cancer patient elevate PSA level .</brief_summary>
	<brief_title>Soy Protein Supplement Preventing Prostate Cancer Patients With Elevated Prostate-Specific Antigen Levels</brief_title>
	<detailed_description>OBJECTIVES : - Compare reduction rate prostatic cellular proliferation patient elevate PSA ( 5 10 ng/mL ) negative biopsy prostate cancer treat daily soy protein supplement vs placebo . - Compare effect regimens additional biomarkers prostate cancer ( PSA , high-grade prostate intraepithelial neoplasia , induction apoptosis , sex steroid receptor expression , loss glutathione S-transferase-pi ) patient . - Compare effect regimens quality life , include urinary sexual function , patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord race ( Caucasian v African American ) . After 2 week daily oral placebo , patient randomize 1 2 arm . - Arm I : Patients receive oral soy protein supplement daily 12 month . - Arm II : Patients receive oral placebo daily 12 month . Quality life assess baseline 6 12 month . PROJECTED ACCRUAL : A total 160 patient ( 80 per arm ) accrue study within 12 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Caseins</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm absence prostate cancer Atypical adenomatous hyperplasia prostatic intraepithelial neoplasia ( highgrade lowgrade ) allow Abnormal baseline transrectal ultrasound digital rectal exam allow Biopsy may study entry , must within past 90 day PSA 510 ng/mL PATIENT CHARACTERISTICS : Age : 50 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No know allergy soy protein milk protein No invasive cancer within past 5 year except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No prior hormonal therapy No prior finasteride No concurrent hormonal therapy No concurrent finasteride Radiotherapy : Not specify Surgery : At least 6 month since prior transurethral resection prostate No prior orchiectomy No concurrent orchiectomy Other : No concurrent soy product</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>prostate cancer</keyword>
</DOC>